Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors
Clinical trial NCT03283202 · COMPLETED
Trial details
- NCT number
- NCT03283202
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-04
- Primary completion
- 2019-07-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.